Skip to main content

Melanoma Clinical Trials

Review the melanoma clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 226-245 of 245

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma
Status: Active
Location: 5 locations
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
Status: Active
Location: 4 locations
A Study of Imaging with Multispectral Optoacoustic Tomography
Status: Active
Location: 3 locations
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
Status: Active
Location: 2 locations
Social Health, Activity Behaviors, and Quality of Life among Young Adult Cancer Survivors
Status: Active
Location: 2 locations
A Study of the Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Features of Atypical/Dysplastic Nevi in Patients with Stage IIB-IIIC Melanoma
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity: A Feasibility Study of the Vigilant App (Vigilant-2)
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer Immunotherapy
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature
Status: Active
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Characterization of the Symptom Experience of Patients with Cutaneous Melanoma Receiving Immune Checkpoint Inhibitor Therapy
Status: Active
Location: University of California San Francisco, San Francisco, California
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
Evaluation for NCI Surgery Branch Clinical Research Protocols
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Circulating Tumor DNA Exposure in Peripheral Blood
Status: Active
Location: See ClinicalTrials.gov
Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies
Status: Enrolling by Invitation
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Harvesting Cells for Experimental Cancer Treatments
Status: Enrolling by Invitation
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Performing MRI Simulation in Treatment Position in Patients Undergoing Spinal Stereotactic Body Radiation Therapy
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
Evaluating Biomarkers of Cognitive Dysfunction in Patients with Cancer
Status: Temporarily Closed to Accrual
Location: University of California San Francisco, San Francisco, California